These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2208242)

  • 21. Prevention and treatment of aluminum overload in uremic patients: long-term results.
    Canavese C; Thea A; Pacitti A; Salomone M; Mangiarotti G; Segoloni G; Stratta P; Gurioli L; Constantini S; Giordini R
    Clin Nephrol; 1989 Apr; 31(4):169-74. PubMed ID: 2714022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desferrioxamine in the treatment of aluminum overload.
    Ackrill P; Day JP
    Clin Nephrol; 1985; 24 Suppl 1():S94-7. PubMed ID: 3842106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperaluminemia associated with liver transplantation and acute renal failure.
    Erasmus RT; Kusnir J; Stevenson WC; Lobo P; Herman MM; Wills MR; Savory J
    Clin Transplant; 1995 Aug; 9(4):307-11. PubMed ID: 7579738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical aspects and applications of hemofiltration.
    Weiss LG
    Scand J Urol Nephrol Suppl; 1989; 118():1-64. PubMed ID: 2785286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of the plasma aluminum concentration of hemodialysis patients].
    Kuleva V; Petrov I; Antonov S; Kiriakov Z
    Vutr Boles; 1984; 23(2):51-5. PubMed ID: 6741112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration.
    Leypoldt JK
    Semin Dial; 2005; 18(5):401-8. PubMed ID: 16191181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodialysis in acute renal failure.
    Taratufolo A; Manzi M; Pedulla F; De Bernardini F; Carofei O; Alaimo MR; Ugolini N; Galeotti P
    EDTNA ERCA J; 1999; 25(3):43-4. PubMed ID: 10786495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aluminium load in patients with analgesic nephropathy.
    Schwarz A; Kraft D; Keller F; Gawlik D; Offermann G
    Miner Electrolyte Metab; 1987; 13(3):141-6. PubMed ID: 3627045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aluminium in continuous ambulatory peritoneal dialysis and post dilutional hemofiltration.
    Mion C
    Clin Nephrol; 1985; 24 Suppl 1():S88-93. PubMed ID: 3915962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aluminium kinetics during haemodialysis with the Redy 2000 Sorbsystem.
    Curtis JR; Sampson B
    Int J Artif Organs; 1989 Nov; 12(11):683-7. PubMed ID: 2599666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
    Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
    Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of medication in the level of aluminium in the blood of chronic haemodialysis patients.
    Bohrer D; Bertagnolli DC; de Oliveira SM; do Nascimento PC; de Carvalho LM; Garcia SC; Arantes LC; Barros EJ
    Nephrol Dial Transplant; 2009 Apr; 24(4):1277-81. PubMed ID: 19028749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
    Kalinowski M; Popławski A; Kaliszewski Z; Juzwiuk J
    Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
    van Landeghem GF; D'Haese PC; Lamberts LV; Djukanovic L; Pejanovic S; Goodman WG; De Broe ME
    Clin Nephrol; 1998 Aug; 50(2):69-76. PubMed ID: 9725776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemodynamics and electrolyte balance: a comparison between on-line pre-dilution haemofiltration and haemodialysis.
    Beerenhout C; Dejagere T; van der Sande FM; Bekers O; Leunissen KM; Kooman JP
    Nephrol Dial Transplant; 2004 Sep; 19(9):2354-9. PubMed ID: 15266029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in intraocular pressure during hemodialysis and hemofiltration].
    Stibor V; Merta M; Lachmanová J
    Cesk Oftalmol; 1992 May; 48(3):161-6. PubMed ID: 1525887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemodialysis during cardiopulmonary bypass using a haemofilter.
    Hamilton CC; Harwood SJ; Deemar KA; Juhasz S; Sharpe E
    Perfusion; 1994 Mar; 9(2):135-9. PubMed ID: 7919599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose calcium carbonate with stepwise reduction in dialysate calcium concentration: effective phosphate control and aluminium avoidance in haemodialysis patients.
    Sawyer N; Noonan K; Altmann P; Marsh F; Cunningham J
    Nephrol Dial Transplant; 1989; 4(2):105-9. PubMed ID: 2496350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational dose predictions for combined treatment of hemofiltration with weekly hemodialysis.
    Lee JC; Park CY; Choi SW; Park JY; Kim JC; Yun YM; Lee KK; Sun K; Min BG
    Comput Methods Programs Biomed; 2008 Mar; 89(3):275-81. PubMed ID: 18155799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of intravenous and intraperitoneal desferrioxamine in aluminium osteomalacia.
    O'Brien AA; McParland C; Keogh JA
    Nephrol Dial Transplant; 1987; 2(2):117-9. PubMed ID: 3112649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.